(Q34378603)

1 August 2017

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Dent J

1

1 reference

1 August 2017

Yeomans ND

2

1 reference

1 August 2017

Mackinnon M

3

1 reference

1 August 2017

Reed W

4

1 reference

1 August 2017

Narielvala FM

5

1 reference

1 August 2017

Hetzel DJ

6

1 reference

1 August 2017

Solcia E

7

1 reference

1 August 2017

Shearman DJ

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

1 August 2017

1 reference

1 August 2017

35

1 reference

1 August 2017

590-598

1 reference

1 August 2017

5

1 reference

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Histopathological classification of nonantral gastric endocrine growths in man.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374738

Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth

27 October 2018

1 reference

12 December 2020

A silver nitrate stain for alpha-2 cells in human pancreatic islets

1 reference

12 December 2020

Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.35.5.590

1 reference

1 August 2017

1 reference

1 August 2017

1 reference